These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1137392)

  • 21. Comparison of the in vitro activity of several cephalosporin antibiotics against gram-negative and gram-positive bacteria resistant to cephaloridine.
    Kisch AL; Bartholomew L
    Antimicrob Agents Chemother; 1976 Sep; 10(3):507-10. PubMed ID: 984793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of susceptibility of ampicillin-resistant enterobacteria to cephalosporins.
    Greenwood D; Chan CH; O'Grady F
    Antimicrob Agents Chemother; 1975 May; 7(5):693-7. PubMed ID: 1041217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klebsiella, Enterobacter, and Serratia: biochemical differentiation and susceptibility to ampicillin and three cephalosporin derivatives.
    Zabransky RJ; Hall JW; Day FE; Needham GM
    Appl Microbiol; 1969 Aug; 18(2):198-203. PubMed ID: 4896880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro activity of cephalosporins.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1976 Feb; 29(2):181-6. PubMed ID: 6411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP; Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ; Washington JA
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of five oral cephalosporins against aerobic pathogenic bacteria.
    Shadomy S; Wagner G; Carver M
    Antimicrob Agents Chemother; 1977 Nov; 12(5):609-13. PubMed ID: 921258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of Haemophilus influenzae type b to cefatrizine, ampicillin, and chloramphenicol.
    Brotherton T; Lees T; Feigin RD
    Antimicrob Agents Chemother; 1976 Aug; 10(2):322-4. PubMed ID: 1086634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Larsson P; Lincoln K; Lind L; Sandberg T
    Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
    Ries K; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Feb; 3(2):168-74. PubMed ID: 4790584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam.
    Yang X; Wang D; Zhou Q; Nie F; Du H; Pang X; Fan Y; Bai T; Xu Y
    BMC Microbiol; 2019 Nov; 19(1):240. PubMed ID: 31675928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J; Levison ME
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins.
    Aswapokee N; Aswapokee P; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Jul; 14(1):1-5. PubMed ID: 686701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of cefazolin against dense populations of enterobacteria.
    Greenwood D; Chan-Teoh CH; O'Grady F
    Antimicrob Agents Chemother; 1975 Feb; 7(2):191-5. PubMed ID: 1137370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
    Lewis RP; Meyer RD; Kraus LL
    Antimicrob Agents Chemother; 1976 May; 9(5):780-6. PubMed ID: 949175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.